Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.
about
Therapy-Related Myeloid NeoplasmsMDS prognostic scoring systems – past, present, and futureTP53 mutation characteristics in therapy-related myelodysplastic syndromes and acute myeloid leukemia is similar to de novo diseases.Myelodysplastic syndromes, version 2.2015Translocation (6;15)(q12;q15): A Novel Mutation in a Patient with Therapy-Related Myelodysplastic Syndrome.Clinical implications of TP53 mutations in myelodysplastic syndromes treated with hypomethylating agents.A focused review of hematopoietic neoplasms occurring in the therapy-related setting.Therapy-related myelodysplastic syndrome.Myelodysplastic Syndromes: Updates and Nuances.Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases.Myelodysplastic syndromes following therapy with hypomethylating agents (HMAs): development of acute erythroleukemia may not influence assessment of treatment response.Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies.The Revised International Prognostic Scoring System (IPSS-R) is not predictive of survival in patients with secondary myelodysplastic syndromes.The prognostic value of circulating myeloblasts in patients with myelodysplastic syndromes.Therapy-related myelodysplastic syndromes-specific risk stratification: are we putting the cart before the horse?Isolated del(5q) in Patients Following Therapies for Various Malignancies May Not All Be Clinically Significant.Is there a pressing need for improving prognostication strategies in therapy-related myelodysplastic syndromes?Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms
P2860
Q26799786-9BFD08FA-956F-42F0-87EB-B128182E7040Q28082460-1E15D88D-438B-4E36-B82B-00EC567ED8D7Q35606212-B2F0F3C5-0FC2-4225-8A4A-6D08214F6A34Q36416338-B57ADCDB-BE33-4150-BDFA-7B3F5DE20D7AQ36422888-6EF0C189-6B7D-4283-842E-E311BDCD70B7Q37046564-8701F260-0BA1-4F63-B2A7-6BD2EB3CAA6CQ38239675-5CFB03D5-D923-4758-9D8D-331EBB01665CQ38353167-7852746A-53D2-4373-B89A-D7C21583FBFCQ38965973-939F4B22-D495-4EBE-9C0B-05ED4AA4DA16Q41299821-5F5817BA-7C57-4CB5-92FA-7D37740A6BBDQ41465409-F107CC9F-A12A-47A0-A407-D6E81C43110DQ41693113-3EC7B731-6C93-4510-B430-27A55F075BD6Q49093274-4B277527-F054-4972-B387-FBED92F4B478Q49721901-E797B7F9-9E9A-40A2-BED1-8E94C49A4F50Q53134785-0497F70E-78C7-4C47-B4B9-EADF19C0B174Q53469467-89787A0E-CCBE-48BD-935D-02C0DC778F67Q53835607-0E6EC869-D555-4528-B63E-48C855F56AB4Q58001836-A8C65E85-0AE6-4303-87F9-2043EF804FE9
P2860
Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Application of the internation ...... lastic acute myeloid leukemia.
@en
Application of the internation ...... lastic acute myeloid leukemia.
@nl
type
label
Application of the internation ...... lastic acute myeloid leukemia.
@en
Application of the internation ...... lastic acute myeloid leukemia.
@nl
prefLabel
Application of the internation ...... lastic acute myeloid leukemia.
@en
Application of the internation ...... lastic acute myeloid leukemia.
@nl
P2093
P2860
P356
P1433
P1476
Application of the internation ...... lastic acute myeloid leukemia.
@en
P2093
G Garcia-Manero
L J Medeiros
R P Hasserjian
P2860
P2888
P304
P356
10.1038/LEU.2013.191
P577
2013-06-21T00:00:00Z